Unlikely to cause harm — often a labeling or packaging issue.
Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.
| Brand name | NORTREL |
| Generic name | NORETHINDRONE AND ETHINYL ESTRADIOL |
| Distributed by / for | Teva Pharmaceuticals USA, Inc |
| NDC | 0555-9008-67 |
| Full product label | Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67 |
| Recalling firm | Teva Pharmaceuticals USA, Inc |
| Distribution | nationwide |
| Quantity | 12,916 cartons |
| Recall initiated | 2024-01-25 |
| Report date | 2024-02-21 |
| Recall completed | — |
| Recall number | D-0321-2024 |
| Classification | Class III |
| FDA status | Ongoing |
| Origin on file | Parsippany NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗